Study #2019-1266
The potential risks and benefits of electronic cigarettes to older smokers at high risk for lung cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Nicotine Replacement
Description
This clinical trial investigates the effects of switching from smoking regular cigarettes to electronic cigarettes (e-cigarettes) among older adult smokers at high risk for lung cancer. E-cigarettes use heated vapor to deliver nicotine. Information gained from this trial may help inform regulators of the potential risks and benefits of switching smokers at high risk for lung cancer to electronic cigarettes. This research also may help inform the Food and Drug Administration (FDA) how best to regulate e-cigarettes with the goal of improving public health.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Lung Carcinoma
Study phase:
Not applicable
Physician name:
Jason Robinson
Department:
Behavioral Science
For general questions about clinical trials:
1-855-401-1031
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.